Raised circulating soluble growth differentiation factor 15 is negatively associated with testosterone level in hypogonadic men with type 2 diabetes. Issue 7 (15th July 2022)

• Record Type: Journal Article
• Authors: Mei, Yufeng; Lyu, Yongnan; Le, Juan; Li, Di; Liu, Hang; Zhao, Zhiming; Li, Yan
• Is Part Of: Diabetes/metabolism research and reviews. Volume 38:Issue 7(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-07-15
• Subjects: GDF‐15 -- male patients -- T2DM -- testosterone; Diabetes -- Periodicals; Metabolism -- Periodicals; 616.642
• DOI: 10.1002/dmrr.3564
• Languages: English
• ISSNs: 1520-7552

Abstract

Abstract: Aims: Epidemiological studies consistently show that decreases in serum testosterone level are observed more frequently in men with type 2 diabetes mellitus (T2DM), while clinical investigations have demonstrated that an increased level of circulating growth differentiation factor‐15 (GDF‐15) are also related closely to T2DM. The aim of this study was to examine the potential relationship between serum GDF‐15 levels and hypogonadism in Chinese male patients with T2DM. Materials and Methods: A total of 305 T2DM men were recruited between July 2020 and August 2021. GDF‐15 and total testosterone concentrations were quantified by an enzyme‐linked immunosorbent assay and LC/MS mass spectrometry, respectively. Multiple linear regression analysis, logistic regression, and restricted cubic splined models were used to examine the correlation between GDF‐15 levels and hypogonadism in these patients. Results: When compared with T2DM patients without hypogonadism circulating GDF‐15 levels were significantly higher in the hypogonadism group [1081.83 (746.79, 1539.94) versus 779.49 (548.46, 1001.27), p < 0.001] and were associated positively with hypogonadism in unadjusted and fully adjusted multivariate regression models ( p < 0.01). The fully adjusted regression coefficients with 95% confidence intervals for circulating GDF‐15 and testosterone deficiency were −1.795 (−2.929, −0.661). Serum GDF‐15 levels were also associated positively with testosterone deficiency in each logistic regression model ( p < 0.05), while after adjustment for all risk factors, the same findings were obtained in the restricted cubic splined models ( p < 0.01). Conclusions: In hypogonadal men with T2DM, an elevated serum GDF‐15 level is associated negatively with serum testosterone concentration. GDF‐15 may be a novel cytokine related to T2DM men with hypogonadism.